Advertisement
Screener

Co-Diagnostics, Inc. (CODX) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

Co-Diagnostics, Inc. Stock-Based Compensation

Co-Diagnostics, Inc. (CODX) reported Stock-Based Compensation of $432.87 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2026-08-13

  • Co-Diagnostics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $213.75K, a 63.16% decline year-over-year.
  • Co-Diagnostics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $219.11K, a 74.96% decline year-over-year.
  • Co-Diagnostics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $291.98K, a 77.85% decline year-over-year.
  • Co-Diagnostics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $500.58K, a 52.12% decline year-over-year.
  • Co-Diagnostics, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $2.25M, a 58.64% decline from fiscal 2024.
  • Co-Diagnostics, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $5.43M, a 34.81% decline from fiscal 2023.
  • Co-Diagnostics, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $8.34M, a 10.52% increase from fiscal 2022.
  • Co-Diagnostics, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $7.54M, a 36.92% increase from fiscal 2021.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 12 month
2026-06-30$213.75K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
$432.87K
10-Q · filed 2026-08-13
$724.84K
derived: sum of 3 quarters · filed 2026-08-13
$1.23M
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31$219.11K
10-Q · filed 2026-05-14
$511.09K
derived: sum of 2 quarters · filed 2026-05-14
$1.01M
derived: sum of 3 quarters · filed 2026-05-14
$1.59M
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31$291.98K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
$792.56K
derived: sum of 2 quarters · filed 2026-03-31
$1.37M
derived: sum of 3 quarters · filed 2026-08-13
$2.25M
10-K · filed 2026-03-31
2025-09-30$500.58K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$1.08M
derived: sum of 2 quarters · filed 2026-08-13
$1.96M
10-Q · filed 2025-11-13
$3.27M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30$580.26K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
$1.46M
10-Q · filed 2026-08-13
$2.77M
derived: sum of 3 quarters · filed 2026-08-13
$3.82M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31$875.23K
10-Q · filed 2026-05-14
$2.19M
derived: sum of 2 quarters · filed 2026-05-14
$3.24M
derived: sum of 3 quarters · filed 2026-05-14
$4.74M
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31$1.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
$2.36M
derived: sum of 2 quarters · filed 2026-03-31
$3.86M
derived: sum of 3 quarters · filed 2026-03-31
$5.43M
10-K · filed 2026-03-31
2024-09-30$1.05M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$2.55M
derived: sum of 2 quarters · filed 2025-11-13
$4.12M
10-Q · filed 2025-11-13
$5.94M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30$1.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
$3.07M
10-Q · filed 2025-08-14
$4.90M
derived: sum of 3 quarters · filed 2025-08-14
$7.07M
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31$1.57M
10-Q · filed 2025-05-08
$3.40M
derived: sum of 2 quarters · filed 2025-05-08
$5.57M
derived: sum of 3 quarters · filed 2025-05-08
$7.74M
derived: sum of 4 quarters · filed 2025-05-08
2023-12-31$1.83M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27
$4.00M
derived: sum of 2 quarters · filed 2025-03-27
$6.17M
derived: sum of 3 quarters · filed 2025-03-27
$8.34M
10-K · filed 2025-03-27
2023-09-30$2.17M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
$4.34M
derived: sum of 2 quarters · filed 2024-11-07
$6.51M
10-Q · filed 2024-11-07
$8.92M
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30$2.17M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
$4.34M
10-Q · filed 2024-08-08
$6.74M
derived: sum of 3 quarters · filed 2024-08-08
$8.97M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31$2.17M
10-Q · filed 2024-05-09
$4.57M
derived: sum of 2 quarters · filed 2024-05-09
$6.80M
derived: sum of 3 quarters · filed 2024-05-09
$8.34M
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31$2.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14
$4.63M
derived: sum of 2 quarters · filed 2024-03-14
$6.17M
derived: sum of 3 quarters · filed 2024-03-14
$7.54M
10-K · filed 2024-03-14
2022-09-30$2.23M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
$3.76M
derived: sum of 2 quarters · filed 2023-11-09
$5.14M
10-Q · filed 2023-11-09
$6.80M
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$1.53M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
$2.91M
10-Q · filed 2023-08-10
$4.57M
derived: sum of 3 quarters · filed 2023-08-10
$5.98M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31$1.38M
10-Q · filed 2023-05-11
$3.03M
derived: sum of 2 quarters · filed 2023-05-11
$4.44M
derived: sum of 3 quarters · filed 2023-05-11
$5.37M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31$1.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
$3.07M
derived: sum of 2 quarters · filed 2023-03-16
$4.00M
derived: sum of 3 quarters · filed 2023-03-16
$5.51M
10-K · filed 2023-03-16
2021-09-30$1.41M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
$2.34M
derived: sum of 2 quarters · filed 2022-11-10
$3.85M
10-Q · filed 2022-11-10
$4.42M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$927.34K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
$2.44M
10-Q · filed 2022-08-11
$3.01M
derived: sum of 3 quarters · filed 2022-08-11
$4.05M
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31$1.51M
10-Q · filed 2022-05-12
$2.08M
derived: sum of 2 quarters · filed 2022-05-12
$3.13M
derived: sum of 3 quarters · filed 2022-05-12
$3.82M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31$570.66K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24
$1.61M
derived: sum of 2 quarters · filed 2022-03-24
$2.31M
derived: sum of 3 quarters · filed 2022-03-24
$2.74M
10-K · filed 2022-03-24
2020-09-30$1.04M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
$1.73M
derived: sum of 2 quarters · filed 2021-11-12
$2.17M
10-Q · filed 2021-11-12
$2.44M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30$691.42K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
$1.12M
10-Q · filed 2021-08-12
$1.40M
derived: sum of 3 quarters · filed 2021-08-12
$1.68M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31$432.82K
10-Q · filed 2021-05-13
$708.78K
derived: sum of 2 quarters · filed 2021-05-13
$984.73K
derived: sum of 3 quarters · filed 2021-05-13
$1.19M
derived: sum of 4 quarters · filed 2021-05-13
2019-12-31$275.95K
10-K · filed 2020-03-30
$551.91K
derived: sum of 2 quarters · filed 2020-03-30
$758.79K
derived: sum of 3 quarters · filed 2020-11-03
$1.09M
10-K · filed 2021-03-25
2019-09-30$275.95K
10-Q · filed 2019-11-12
$482.84K
derived: sum of 2 quarters · filed 2020-11-03
$570.63K
10-Q · filed 2020-11-16
$1.33M
derived: sum of 4 quarters · filed 2020-11-03
2019-06-30$206.88K
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-11-03
$294.68K
10-Q/A · filed 2020-11-03
$1.06M
derived: sum of 3 quarters · filed 2020-11-03
$1.55M
derived: sum of 4 quarters · filed 2020-11-03
2019-03-31$87.79K
10-Q · filed 2020-05-14
$849.80K
derived: sum of 2 quarters · filed 2020-05-14
$1.35M
derived: sum of 3 quarters · filed 2020-05-14
$1.40M
derived: sum of 4 quarters · filed 2020-05-14
2018-12-31$762.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30
$1.26M
derived: sum of 2 quarters · filed 2020-03-30
$1.31M
derived: sum of 3 quarters · filed 2020-03-30
$1.33M
10-K · filed 2020-03-30
2018-09-30$495.38K
10-Q · filed 2019-11-12
$545.38K
derived: sum of 2 quarters · filed 2019-11-12
$570.38K
10-Q · filed 2019-11-12
$1.93M
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30$50.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
$75.00K
10-Q · filed 2019-08-14
$1.43M
derived: sum of 3 quarters · filed 2019-08-14
$1.54M
derived: sum of 4 quarters · filed 2019-08-14
2018-03-31$25.00K
10-Q · filed 2019-05-14
$1.38M
derived: sum of 2 quarters · filed 2019-05-14
$1.49M
derived: sum of 3 quarters · filed 2019-05-14
$1.49M
derived: sum of 4 quarters · filed 2019-05-14
2017-12-31$1.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01
$1.46M
derived: sum of 2 quarters · filed 2019-04-01
$1.47M
derived: sum of 3 quarters · filed 2019-04-01
$2.03M
10-K · filed 2019-04-01
2017-09-30$103.67K
10-Q · filed 2017-11-14
$109.87K
derived: sum of 2 quarters · filed 2018-08-10
$675.97K
10-Q · filed 2018-11-14
$126.75K
derived: sum of 4 quarters · filed 2018-08-10
2017-06-30$6.20K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10
$12.40K
10-Q · filed 2018-08-10
$23.08K
derived: sum of 3 quarters · filed 2018-08-10
$33.21K
derived: sum of 4 quarters · filed 2018-08-10
2017-03-31$6.20K
10-Q · filed 2018-05-14
$16.88K
derived: sum of 2 quarters · filed 2018-05-14
$27.01K
derived: sum of 3 quarters · filed 2018-05-14
2016-12-31$10.69K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28
$20.82K
derived: sum of 2 quarters · filed 2018-03-28
$69.56K
10-K · filed 2018-03-28
2016-09-30$10.13K
10-Q · filed 2017-11-14
$58.88K
10-Q · filed 2017-11-14
2016-06-30$48.75K
10-Q · filed 2017-08-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
enVVeno Medical Corp (NVNO)United States$0.006B-0.48
Sonoma Pharmaceuticals, Inc. (SNOA)United States$0.006B-2.59
INTELLIGENT BIO SOLUTIONS INC. (INBS)United States$0.005B
AETHLON MEDICAL INC (AEMD)United States$0.005B
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
ALLURION TECHNOLOGIES, INC. (ALUR)United States$0.010B
Autonomix Medical, Inc. (AMIX)United States$0.004B
Picard Medical, Inc. (PMI)United States$0.011B-0.01